Molly Henderson, CFO and CBO at Phathom Pharmaceuticals, Inc. (PHAT), sold 6,307 shares at $7.75 ($49K) on 2024-01-19, disclosed to the SEC on 2024-01-22.
Open-market sale of $49k PHAT by CFO and CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PHAT | SELL | 2024-12-20 | $10K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $51K | — | Filing → |
| PHAT | SELL | 2024-04-10 | $38K | — | Filing → |